These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 25711199)

  • 21. Biopsy-Integrated 3D Magnetic Resonance Imaging Modeling of Prostate Cancer and Its Application for Gleason Grade and Tumor Laterality Assessment.
    Kim J; Lim B; Jeong IG; Ro JY; Go H; Cho YM; Park KJ
    Arch Pathol Lab Med; 2023 Feb; 147(2):159-166. PubMed ID: 35512234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptome Wide Analysis of Magnetic Resonance Imaging-targeted Biopsy and Matching Surgical Specimens from High-risk Prostate Cancer Patients Treated with Radical Prostatectomy: The Target Must Be Hit.
    Radtke JP; Takhar M; Bonekamp D; Kesch C; Erho N; du Plessis M; Buerki C; Ong K; Davicioni E; Hohenfellner M; Hadaschik BA
    Eur Urol Focus; 2018 Jul; 4(4):540-546. PubMed ID: 28753844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting Pathological Tumor Size in Prostate Cancer Based on Multiparametric Prostate Magnetic Resonance Imaging and Preoperative Findings.
    Pooli A; Johnson DC; Shirk J; Markovic D; Sadun TY; Sisk AE; Mohammadian Bajgiran A; Afshari Mirak S; Felker ER; Hughes AK; Raman SS; Reiter RE
    J Urol; 2021 Feb; 205(2):444-451. PubMed ID: 33026934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of unfavorable disease after radical prostatectomy in patients at low risk by D'Amico criteria: role of multiparametric magnetic resonance imaging.
    Song SH; Pak S; Park S; Song C; Jeong IG; Choi HJ; Kim JK; Cho KS; Kim CS; Ahn H
    J Urol; 2014 Aug; 192(2):402-8. PubMed ID: 24631106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pathological findings of visible and non-visible tumors on multiparametric magnetic resonance imaging (MRI) prior to radical prostatectomy].
    Rivière A; Cornud F; Beuvon F; Sibony M; Legmann P; Barry Delongchamps N
    Prog Urol; 2017 Sep; 27(10):536-542. PubMed ID: 28867582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implications of unconventional histological subtypes on magnetic resonance imaging and oncological outcomes in patients who have undergone radical prostatectomy.
    Kurokawa K; Yamada Y; Sakamoto S; Horikoshi T; Sato K; Nanba S; Kubota Y; Kanesaka M; Fujimoto A; Takeuchi N; Shibata H; Sazuka T; Imamura Y; Tsuzuki T; Uno T; Ichikawa T
    Sci Rep; 2024 Jun; 14(1):14868. PubMed ID: 38937563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparing Image-guided targeted Biopsies to Radical Prostatectomy Specimens for Accurate Characterization of the Index Tumor in Prostate Cancer.
    Porpiglia F; DE Luca S; Checcucci E; Garrou D; Manfredi M; Mele F; Pecoraro A; Passera R; Bollito E; Fiori C
    Anticancer Res; 2018 May; 38(5):3043-3047. PubMed ID: 29715138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Added Value of Multiparametric Magnetic Resonance Imaging to Clinical Nomograms for Predicting Adverse Pathology in Prostate Cancer.
    Rayn KN; Bloom JB; Gold SA; Hale GR; Baiocco JA; Mehralivand S; Czarniecki M; Sabarwal VK; Valera V; Wood BJ; Merino MJ; Choyke P; Turkbey B; Pinto PA
    J Urol; 2018 Nov; 200(5):1041-1047. PubMed ID: 29852182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Gleason Subtype on Prostate Cancer Detection Using Multiparametric Magnetic Resonance Imaging: Correlation with Final Histopathology.
    Truong M; Hollenberg G; Weinberg E; Messing EM; Miyamoto H; Frye TP
    J Urol; 2017 Aug; 198(2):316-321. PubMed ID: 28163032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiomics Features Measured with Multiparametric Magnetic Resonance Imaging Predict Prostate Cancer Aggressiveness.
    Hectors SJ; Cherny M; Yadav KK; Beksaç AT; Thulasidass H; Lewis S; Davicioni E; Wang P; Tewari AK; Taouli B
    J Urol; 2019 Sep; 202(3):498-505. PubMed ID: 30958743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Focused Submission of Tissue for Radical Prostatectomy Following Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion-Targeted Biopsy.
    Fasciano D; Eich ML; Del Carmen Rodriguez Pena M; Rais-Bahrami S; Gordetsky J
    Int J Surg Pathol; 2020 Feb; 28(1):44-50. PubMed ID: 31342804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of targeted MR-guided prostate biopsy reduces the risk of Gleason upgrading on radical prostatectomy.
    Arsov C; Becker N; Rabenalt R; Hiester A; Quentin M; Dietzel F; Antoch G; Gabbert HE; Albers P; Schimmöller L
    J Cancer Res Clin Oncol; 2015 Nov; 141(11):2061-8. PubMed ID: 26013424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toward Prostate Cancer Contouring Guidelines on Magnetic Resonance Imaging: Dominant Lesion Gross and Clinical Target Volume Coverage Via Accurate Histology Fusion.
    Gibson E; Bauman GS; Romagnoli C; Cool DW; Bastian-Jordan M; Kassam Z; Gaed M; Moussa M; Gómez JA; Pautler SE; Chin JL; Crukley C; Haider MA; Fenster A; Ward AD
    Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):188-96. PubMed ID: 27375167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of Upgrading from Prostate Biopsy to Radical Prostatectomy Pathology-Does Saturation Biopsy of Index Lesion during Multiparametric Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Biopsy Help?
    Calio BP; Sidana A; Sugano D; Gaur S; Maruf M; Jain AL; Merino MJ; Choyke PL; Wood BJ; Pinto PA; Turkbey B
    J Urol; 2018 Apr; 199(4):976-982. PubMed ID: 29154904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Role of Magnetic Resonance Image Guided Prostate Biopsy in Stratifying Men for Risk of Extracapsular Extension at Radical Prostatectomy.
    Raskolnikov D; George AK; Rais-Bahrami S; Turkbey B; Siddiqui MM; Shakir NA; Okoro C; Rothwax JT; Walton-Diaz A; Sankineni S; Su D; Stamatakis L; Merino MJ; Choyke PL; Wood BJ; Pinto PA
    J Urol; 2015 Jul; 194(1):105-111. PubMed ID: 25623751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Whole-lesion apparent diffusion coefficient metrics as a marker of percentage Gleason 4 component within Gleason 7 prostate cancer at radical prostatectomy.
    Rosenkrantz AB; Triolo MJ; Melamed J; Rusinek H; Taneja SS; Deng FM
    J Magn Reson Imaging; 2015 Mar; 41(3):708-14. PubMed ID: 24616064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gleason score and tumor laterality in radical prostatectomy and transrectal ultrasound-guided biopsy of the prostate: a comparative study.
    Pereira RA; Costa RS; Muglia VF; Silva FF; Lajes JS; Dos Reis RB; Silva GE
    Asian J Androl; 2015; 17(5):815-20. PubMed ID: 25652629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MRI-guided focal laser ablation for prostate cancer followed by radical prostatectomy: correlation of treatment effects with imaging.
    Bomers JGR; Cornel EB; Fütterer JJ; Jenniskens SFM; Schaafsma HE; Barentsz JO; Sedelaar JPM; Hulsbergen-van de Kaa CA; Witjes JA
    World J Urol; 2017 May; 35(5):703-711. PubMed ID: 27541586
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Image-directed, tissue-preserving focal therapy of prostate cancer: a feasibility study of a novel deformable magnetic resonance-ultrasound (MR-US) registration system.
    Dickinson L; Hu Y; Ahmed HU; Allen C; Kirkham AP; Emberton M; Barratt D
    BJU Int; 2013 Sep; 112(5):594-601. PubMed ID: 23819525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathologic correlation of transperineal in-bore 3-Tesla magnetic resonance imaging-guided prostate biopsy samples with radical prostatectomy specimen.
    Velez E; Fedorov A; Tuncali K; Olubiyi O; Allard CB; Kibel AS; Tempany CM
    Abdom Radiol (NY); 2017 Aug; 42(8):2154-2159. PubMed ID: 28293720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.